Research & Development



  “巴澤爾已經把藥典通譯完畢了。”甦稚趴在雲瑯的窗口沖著雲瑯笑,而衛伉就跟在甦稚身後,看雲瑯的眼神滿是敵意。   霍去病開始突襲必定是一路上勢如龍卷,雞犬不留的,這是在受降城的時候就已經制定的方略。超碰免费公开   衛青家的孩子,如何會不知道死士營是個什麼所在,那里本身就是罪囚,死囚待的地方。好人在那里待久了都會發瘋,畢竟,等死的日子很不好過。CaoPorn超碰免费视频   你雲瑯不知道是怎麼壯著膽子才發起戰車沖鋒的,幾乎死在亂軍中。   以後會形成一個惡性循環。caoporn免费超碰在线   雲瑯沒有看小狗子哪怕一眼,他熾熱的情感全部給了霍去病跟李敢,以及趙破奴。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo